- Home
- MLSS
as of 12-05-2025 4:00pm EST
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | LIVINGSTON |
| Market Cap: | 23.7M | IPO Year: | 1995 |
| Target Price: | $1.00 | AVG Volume (30 days): | 3.2M |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.08 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.28 - $1.39 | Next Earning Date: | 11-13-2025 |
| Revenue: | $8,929,517 | Revenue Growth: | 0.59% |
| Revenue Growth (this year): | 8.95% | Revenue Growth (next year): | 7.51% |
AI-Powered MLSS Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Milestone Scientific Inc. (MLSS)
10% Owner
Avg Cost/Share
$0.44
Shares
200,000
Total Value
$87,960.00
Owned After
8,896,765
10% Owner
Avg Cost/Share
$0.43
Shares
160,000
Total Value
$68,832.00
Owned After
8,896,765
10% Owner
Avg Cost/Share
$0.45
Shares
28,854
Total Value
$12,975.64
Owned After
8,896,765
10% Owner
Avg Cost/Share
$0.44
Shares
40,000
Total Value
$17,592.00
Owned After
8,896,765
SEC Form 4
10% Owner
Avg Cost/Share
$0.45
Shares
24,034
Total Value
$10,880.19
Owned After
8,896,765
SEC Form 4
10% Owner
Avg Cost/Share
$0.54
Shares
30,000
Total Value
$16,185.00
Owned After
8,896,765
SEC Form 4
10% Owner
Avg Cost/Share
$0.55
Shares
10,000
Total Value
$5,500.00
Owned After
8,896,765
SEC Form 4
10% Owner
Avg Cost/Share
$0.55
Shares
10,158
Total Value
$5,587.92
Owned After
8,896,765
SEC Form 4
10% Owner
Avg Cost/Share
$0.47
Shares
30,000
Total Value
$13,950.00
Owned After
8,896,765
SEC Form 4
10% Owner
Avg Cost/Share
$0.45
Shares
10,000
Total Value
$4,500.00
Owned After
8,896,765
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| BP4 S.r.l. | MLSS | 10% Owner | Oct 24, 2025 | Sell | $0.44 | 200,000 | $87,960.00 | 8,896,765 | |
| BP4 S.r.l. | MLSS | 10% Owner | Oct 23, 2025 | Sell | $0.43 | 160,000 | $68,832.00 | 8,896,765 | |
| BP4 S.r.l. | MLSS | 10% Owner | Oct 22, 2025 | Sell | $0.45 | 28,854 | $12,975.64 | 8,896,765 | |
| BP4 S.r.l. | MLSS | 10% Owner | Oct 21, 2025 | Sell | $0.44 | 40,000 | $17,592.00 | 8,896,765 | |
| BP4 S.r.l. | MLSS | 10% Owner | Oct 20, 2025 | Sell | $0.45 | 24,034 | $10,880.19 | 8,896,765 | |
| BP4 S.r.l. | MLSS | 10% Owner | Oct 14, 2025 | Sell | $0.54 | 30,000 | $16,185.00 | 8,896,765 | |
| BP4 S.r.l. | MLSS | 10% Owner | Oct 13, 2025 | Sell | $0.55 | 10,000 | $5,500.00 | 8,896,765 | |
| BP4 S.r.l. | MLSS | 10% Owner | Oct 10, 2025 | Sell | $0.55 | 10,158 | $5,587.92 | 8,896,765 | |
| BP4 S.r.l. | MLSS | 10% Owner | Oct 8, 2025 | Sell | $0.47 | 30,000 | $13,950.00 | 8,896,765 | |
| BP4 S.r.l. | MLSS | 10% Owner | Oct 7, 2025 | Sell | $0.45 | 10,000 | $4,500.00 | 8,896,765 |
Compare MLSS vs Leading Stocks
See how MLSS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "MLSS Milestone Scientific Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.